122 related articles for article (PubMed ID: 11157908)
1. Synergic activity of D-cycloserine and beta-chloro-D-alanine against Mycobacterium tuberculosis.
David S
J Antimicrob Chemother; 2001 Feb; 47(2):203-6. PubMed ID: 11157908
[TBL] [Abstract][Full Text] [Related]
2. Glutamate Racemase Is the Primary Target of β-Chloro-d-Alanine in Mycobacterium tuberculosis.
Prosser GA; Rodenburg A; Khoury H; de Chiara C; Howell S; Snijders AP; de Carvalho LP
Antimicrob Agents Chemother; 2016 Oct; 60(10):6091-9. PubMed ID: 27480853
[TBL] [Abstract][Full Text] [Related]
3. Molecular basis underlying Mycobacterium tuberculosis D-cycloserine resistance. Is there a role for ubiquinone and menaquinone metabolic pathways?
Hong W; Chen L; Xie J
Expert Opin Ther Targets; 2014 Jun; 18(6):691-701. PubMed ID: 24773568
[TBL] [Abstract][Full Text] [Related]
4. Suppression of beta-lactam antibiotic resistance in a methicillin-resistant Staphylococcus aureus through synergic action of early cell wall inhibitors and some other antibiotics.
Sieradzki K; Tomasz A
J Antimicrob Chemother; 1997 May; 39 Suppl A():47-51. PubMed ID: 9511062
[TBL] [Abstract][Full Text] [Related]
5. Role of Alanine Racemase Mutations in Mycobacterium tuberculosis d-Cycloserine Resistance.
Nakatani Y; Opel-Reading HK; Merker M; Machado D; Andres S; Kumar SS; Moradigaravand D; Coll F; Perdigão J; Portugal I; Schön T; Nair D; Devi KRU; Kohl TA; Beckert P; Clark TG; Maphalala G; Khumalo D; Diel R; Klaos K; Aung HL; Cook GM; Parkhill J; Peacock SJ; Swaminathan S; Viveiros M; Niemann S; Krause KL; Köser CU
Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971867
[TBL] [Abstract][Full Text] [Related]
6. Metabolomics analysis identifies d-Alanine-d-Alanine ligase as the primary lethal target of d-Cycloserine in mycobacteria.
Halouska S; Fenton RJ; Zinniel DK; Marshall DD; Barletta RG; Powers R
J Proteome Res; 2014 Feb; 13(2):1065-76. PubMed ID: 24303782
[TBL] [Abstract][Full Text] [Related]
7. Structure of the Mycobacterium tuberculosis D-alanine:D-alanine ligase, a target of the antituberculosis drug D-cycloserine.
Bruning JB; Murillo AC; Chacon O; Barletta RG; Sacchettini JC
Antimicrob Agents Chemother; 2011 Jan; 55(1):291-301. PubMed ID: 20956591
[TBL] [Abstract][Full Text] [Related]
8. The effect of beta-chloro D-alanine and L-cycloserine on the serine, phosphorus and palmitic acid uptake and metabolism of Tetrahymena lipids.
Kovács P
Acta Biol Hung; 1999; 50(4):363-73. PubMed ID: 10735173
[TBL] [Abstract][Full Text] [Related]
9. Activity of the combination of fludalanine and cycloserine against mycobacteria in vitro.
Dickinson JM; Mitchison DA
Tubercle; 1985 Jun; 66(2):109-15. PubMed ID: 4024268
[TBL] [Abstract][Full Text] [Related]
10. Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine.
Feng Z; Barletta RG
Antimicrob Agents Chemother; 2003 Jan; 47(1):283-91. PubMed ID: 12499203
[TBL] [Abstract][Full Text] [Related]
11. Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance.
Desjardins CA; Cohen KA; Munsamy V; Abeel T; Maharaj K; Walker BJ; Shea TP; Almeida DV; Manson AL; Salazar A; Padayatchi N; O'Donnell MR; Mlisana KP; Wortman J; Birren BW; Grosset J; Earl AM; Pym AS
Nat Genet; 2016 May; 48(5):544-51. PubMed ID: 27064254
[TBL] [Abstract][Full Text] [Related]
12. Resistance to D-cycloserine in the tubercle bacilli: mutation rate and transport of alanine in parental cells and drug-resistant mutants.
David HL
Appl Microbiol; 1971 May; 21(5):888-92. PubMed ID: 4995732
[TBL] [Abstract][Full Text] [Related]
13. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments].
Tsukamura M
Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817
[TBL] [Abstract][Full Text] [Related]
14. Reinterpreting the mechanism of inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by D-cycloserine.
Prosser GA; de Carvalho LP
Biochemistry; 2013 Oct; 52(40):7145-9. PubMed ID: 24033232
[TBL] [Abstract][Full Text] [Related]
15. Mechanism-Based Inhibition of the Mycobacterium tuberculosis Branched-Chain Aminotransferase by d- and l-Cycloserine.
Amorim Franco TM; Favrot L; Vergnolle O; Blanchard JS
ACS Chem Biol; 2017 May; 12(5):1235-1244. PubMed ID: 28272868
[TBL] [Abstract][Full Text] [Related]
16. N(2)-substituted D,L-cycloserine derivatives: synthesis and evaluation as alanine racemase inhibitors.
Kim MG; Strych U; Krause K; Benedik M; Kohn H
J Antibiot (Tokyo); 2003 Feb; 56(2):160-8. PubMed ID: 12715876
[TBL] [Abstract][Full Text] [Related]
17. [In vitro antibacterial activity of a halogenated derivative of D-alanine].
Viano I; Santiano M; Savoia D
G Batteriol Virol Immunol; 1979; 72(1-6):134-42. PubMed ID: 121980
[TBL] [Abstract][Full Text] [Related]
18. [A preliminary study on the molecular characteristics of D-cycloserine resistance of
Li C; Li GL; Luo Q; Li SJ; Wang RB; Lou YL; Lyu JX; Wan KL
Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Feb; 38(2):240-243. PubMed ID: 28231674
[No Abstract] [Full Text] [Related]
19. Kinetic mechanism and inhibition of Mycobacterium tuberculosis D-alanine:D-alanine ligase by the antibiotic D-cycloserine.
Prosser GA; de Carvalho LP
FEBS J; 2013 Feb; 280(4):1150-66. PubMed ID: 23286234
[TBL] [Abstract][Full Text] [Related]
20. [Frequency of Mycobacterium tuberculosis L-form induction under the influence of cycloserine and its combinations with other drugs].
Dorozhkova IR; Volk AV
Antibiotiki; 1972 Sep; 17(9):838-44. PubMed ID: 4120084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
